Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Bottino

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|July 20, 2004
Commentary: Regulated equilibrium between opposite signals: a general paradigm for T cell function?Alessandro Moretta, Cristina Bottino
Cells|March 29, 2023
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer CellsChiara Vitale, Cristina Bottino, Roberta Castriconi
Molecular Aspects of Medicine|June 28, 2021
Inhibitory axes impacting on the activity and fate of Innate Lymphoid CellsCristina Bottino, Alessandra Dondero, Roberta Castriconi
Cancers|July 14, 2023
B7-H3 in Pediatric Tumors: Far beyond NeuroblastomaCristina Bottino, Chiara Vitale, Alessandra Dondero, et al.
Trends in Immunology|March 31, 2005
Cellular ligands of activating NK receptorsCristina Bottino, Roberta Castriconi, Lorenzo Moretta, et al.
Plos One|September 24, 2013
Transcriptional profiling of human monocytes identifies the inhibitory receptor CD300a as regulator of transendothelial migrationSharang Ghavampour, Carsten Lange, Cristina Bottino, et al.
Current Protocols in Immunology|April 25, 2008
Human natural killer receptors and their ligandsRoberto Biassoni, Cristina Bottino, Claudia Cantoni, et al.
Immunological Reviews|August 24, 2024
Natural killer cells and engagers: Powerful weapons against cancerCristina Bottino, Valentin Picant, Eric Vivier, et al.
Current Pharmaceutical Design|August 11, 2011
New perspectives in glioma immunotherapyAntonio Daga, Cristina Bottino, Roberta Castriconi, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infectionDaniela Pende, Raffaella Meazza, Stefania Marcenaro, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|July 20, 2004
Commentary: Regulated equilibrium between opposite signals: a general paradigm for T cell function?Alessandro Moretta, Cristina Bottino
Cells|March 29, 2023
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer CellsChiara Vitale, Cristina Bottino, Roberta Castriconi
Molecular Aspects of Medicine|June 28, 2021
Inhibitory axes impacting on the activity and fate of Innate Lymphoid CellsCristina Bottino, Alessandra Dondero, Roberta Castriconi
Cancers|July 14, 2023
B7-H3 in Pediatric Tumors: Far beyond NeuroblastomaCristina Bottino, Chiara Vitale, Alessandra Dondero, et al.
Trends in Immunology|March 31, 2005
Cellular ligands of activating NK receptorsCristina Bottino, Roberta Castriconi, Lorenzo Moretta, et al.
Plos One|September 24, 2013
Transcriptional profiling of human monocytes identifies the inhibitory receptor CD300a as regulator of transendothelial migrationSharang Ghavampour, Carsten Lange, Cristina Bottino, et al.
Current Protocols in Immunology|April 25, 2008
Human natural killer receptors and their ligandsRoberto Biassoni, Cristina Bottino, Claudia Cantoni, et al.
Immunological Reviews|August 24, 2024
Natural killer cells and engagers: Powerful weapons against cancerCristina Bottino, Valentin Picant, Eric Vivier, et al.
Current Pharmaceutical Design|August 11, 2011
New perspectives in glioma immunotherapyAntonio Daga, Cristina Bottino, Roberta Castriconi, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infectionDaniela Pende, Raffaella Meazza, Stefania Marcenaro, et al.
Pageof 9